Pharmacie Boden SA
Pharmacie Boden reported total assets of 267,278 € at the end of the 2025 financial year (annual accounts filed with the NBB on 10 Jun 2026).
The score of Pharmacie Boden shows with a free account.
See the score- Summary? / 5
- Balance sheet strength
- Liquidity
- Repayment capacity
- Profitability
- Trajectory
- Compliance and register
- Position in its sectorvs peers
- Supplier creditat 30 d
- Borrowing capacityborrowable
- Valuationcentral
Visible once signed in: create your account, the 14-day Pro trial is free.
Key figures 2025
Change 2022 → 2025: Total assets -60 %
Accounts of the company itself (not consolidated).
The full file covers 10 financial years; a free account shows 2. →Deterministic calculation on the filed accounts, no AI. Dispute the score or report an error
Pharmacie Boden's annual accounts
| 2025 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|
| Net result | 3,671 € | ||||
| Equity | −144,935 € | ||||
| Cash | 13,341 € | ||||
| EBITDA | 77,640 € | ||||
| Total assets | 267,278 € |
Filed annual accounts
- Year ended 31 Dec 2025filed on 10 Jun 2026
- Year ended 31 Dec 2024filed on 06 Aug 2025
- Year ended 31 Dec 2023filed on 27 Aug 2024
- Year ended 31 Dec 2022filed on 31 Aug 2023
- Year ended 31 Dec 2021filed on 30 Sep 2022
Pharmacie Boden's financial analysis
- Solvency-54.2%sector median: 41.5%
- Current ratio
- Net margin
- ROE
- Financial debt / EBITDA
- Interest coverage
- Days sales outstanding (DSO)
Management and control of Pharmacie Boden
Pharmacie Boden's publications in the Belgian Gazette
Company number, VAT number and registered office
- Company number (CBE)
- 0874.169.146
- VAT number
- BE0874169146
- Peppol
- Registered · 0208:0874169146 · as of 10 Nov 2026
- Legal form
- SA
- Incorporated
- 31 May 2005
- Registered office
- 4100 Seraing
- Latest accounts
- 2025 · filed on 10 Jun 2026
- Activity
- Retail sale of pharmaceutical products (NACE 47730)
Pharmacie Boden (SA) has been based in Seraing since 2005, active in: retail sale of pharmaceutical products. For 2025, it reports a net profit of 3,671 € and equity of −144,935 €; its revenue is not published.
Guide: Reading Belgian SME accounts: the five figures that count →
Companies similar to Pharmacie Boden
Companies in the same business, of comparable size and area, outside its group.
- Vereenooghe LDL Retail sale of pharmaceutical products Lendelede · balance sheet 377,699 €
- EDEHealth Services Business and other management consultancy activities Beyne-Heusay · balance sheet 23,732 €
- Apotheek de Kempen Retail sale of pharmaceutical products Turnhout · balance sheet 424,571 €
- Apoteek de Smedt Retail sale of pharmaceutical products Asse · balance sheet 343,684 €
- Koltfarma Retail sale of pharmaceutical products Charleroi · balance sheet 488,225 €
- Humbeek Pharma Retail sale of pharmaceutical products Grimbergen · balance sheet 653,604 €
- Blauwblomme Retail sale of pharmaceutical products Kortrijk · balance sheet 559,420 €
- Pharm-OZ Retail sale of pharmaceutical products Charleroi · balance sheet 681,585 €
Frequently asked questions about Pharmacie Boden
What is the revenue of Pharmacie Boden?
Pharmacie Boden files its accounts in a format where revenue is optional: it is not published for 2025.
What is the VAT number of Pharmacie Boden?
In Belgium, the VAT number is the company number prefixed with BE: BE0874169146 for Pharmacie Boden, if the company is VAT-registered. Its company number (CBE) is 0874.169.146.
Where is the registered office of Pharmacie Boden?
According to the CBE register, the registered office of Pharmacie Boden is in 4100 Seraing.
What is the equity of Pharmacie Boden?
At the close of the 2025 financial year, the equity of Pharmacie Boden amounts to -144,935 €, a solvency of -54.2% of total assets.
Who manages Pharmacie Boden?
The register lists 5 active mandates at Pharmacie Boden. Names and roles are in the full file, with the deeds published in the Belgian Gazette.
The full file of Pharmacie Boden
Directors and mandates, ownership network, Gazette deeds, ten years of accounts and ratios, Excel export, and Idonis's analysis in one question.
Open the full file →